Related Experiment Videos

Actin-associated proteins and cardiomyopathy-the 'unknown' beyond troponin and tropomyosin

Elisabeth Ehler1,2

  • 1Randall Centre for Cell and Molecular Biophysics (School of Basic and Medical Biosciences), London, UK. elisabeth.ehler@kcl.ac.uk.

Biophysical Reviews
|June 6, 2018
PubMed

Insights

Mutations in proteins regulating heart muscle contraction, like troponin, cause hypertrophic cardiomyopathy. Emerging research shows other actin-binding proteins also contribute to heart disease development.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Genetics

Background:

  • Hereditary hypertrophic cardiomyopathy is linked to mutations in proteins controlling actomyosin interactions (e.g., troponin complex, tropomyosin, MYBP-C).
  • Recent studies indicate that actin-binding proteins not directly involved in contraction regulation may also play a role in heart disease.

Purpose of the Study:

  • To review actin-associated proteins beyond the troponin/tropomyosin complex.
  • To explore the roles of these proteins in cardiomyocytes.
  • To discuss their recent association with hereditary cardiomyopathies.

Main Methods:

  • Literature review of genetic and molecular studies.
  • Analysis of protein expression, localization, and mutation data.
  • Synthesis of findings on actin-binding proteins and heart disease.

Main Results:

  • Identified various actin-associated proteins implicated in heart function.
  • Highlighted changes in expression, localization, and mutations of these proteins.
  • Established potential links between these proteins and cardiomyopathies.

Conclusions:

  • Actin-binding proteins, beyond those directly regulating contraction, are crucial in cardiomyocyte function.
  • Alterations in these proteins represent a growing area of research for hereditary cardiomyopathies.
  • Further investigation into these proteins may reveal new therapeutic targets for heart disease.

Related Concept Videos